Details for New Drug Application (NDA): 212238
✉ Email this page to a colleague
The generic ingredient in TRIENTINE HYDROCHLORIDE is trientine hydrochloride. There are ten drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the trientine hydrochloride profile page.
Summary for 212238
Tradename: | TRIENTINE HYDROCHLORIDE |
Applicant: | Rising |
Ingredient: | trientine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 212238
Mechanism of Action | Copper Chelating Activity Metal Chelating Activity |
Medical Subject Heading (MeSH) Categories for 212238
Suppliers and Packaging for NDA: 212238
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TRIENTINE HYDROCHLORIDE | trientine hydrochloride | CAPSULE;ORAL | 212238 | ANDA | Rising Pharma Holdings, Inc. | 16571-810 | 16571-810-01 | 100 CAPSULE in 1 BOTTLE (16571-810-01) |
TRIENTINE HYDROCHLORIDE | trientine hydrochloride | CAPSULE;ORAL | 212238 | ANDA | Rising Pharma Holdings, Inc. | 16571-812 | 16571-812-05 | 50 CAPSULE in 1 BOTTLE (16571-812-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 250MG | ||||
Approval Date: | Feb 20, 2020 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 500MG | ||||
Approval Date: | Sep 22, 2023 | TE: | RLD: | No |
Complete Access Available with Subscription